Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bausch Lomb Ord Shs T.BLCO

Alternate Symbol(s):  BLCO

Healthcare Medical Devices
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative... see more

Recent & Breaking News (TSX:BLCO)

Bausch + Lomb's ONE by ONE and Biotrue® Eye Care Recycling Programs Win Gold for Most Environmentally Friendly Service of the Year from Best in Biz Awards

PR Newswire December 12, 2022

Bausch + Lomb's Biotrue® Hydration Plus Multi-Purpose Solution Receives Product of the Year Award from Business Intelligence Group's 2022 BIG Awards for Business

PR Newswire November 29, 2022

Bausch + Lomb Reports More Than 58 Million Units of Contact Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs

PR Newswire November 15, 2022

Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference

PR Newswire November 7, 2022

Bausch + Lomb Announces Third-Quarter 2022 Results

PR Newswire November 2, 2022

Bausch + Lomb #LUMIFYEyeDance Challenge Wins 2022 Public Relations and Marketing Excellence Award for External Campaign of the Year from Business Intelligence Group

PR Newswire November 1, 2022

Bausch + Lomb Introduces Project Watson(TM) Health Care Products for Dogs

PR Newswire October 24, 2022

Bausch + Lomb Announces Presentation of Scientific Data and Analyses Evaluating Biotrue® Hydration Plus Multi-Purpose Solution at American Academy of Optometry Annual Meeting

PR Newswire October 18, 2022

Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2

PR Newswire October 4, 2022

Bausch + Lomb Introduces Enhanced Ocuvite® Adult 50+ Eye Vitamin Formulation With Vitamin D

PR Newswire October 3, 2022

Bausch + Lomb Will Present Scientific Data and Analyses During World Cornea Congress

PR Newswire September 27, 2022

Bausch + Lomb Will Present New Scientific Data and Analyses During the American Academy of Ophthalmology Annual Meeting

Canada NewsWire September 26, 2022

Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings

PR Newswire September 21, 2022

First Annual Bausch + Lomb Sponsored Visionary Report Spotlights Nation's 'Blind Spots' on Age-related Macular Degeneration, a Leading Cause of Vision Loss for People 50+

PR Newswire September 13, 2022

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance for Investigational Treatment NOV03 (Perfluorohexyloctane)

PR Newswire September 6, 2022

Bausch+Lomb (TSX:BLCO) named exclusive global distributor of Alfa Instruments

Shoran Devi September 1, 2022

Bausch + Lomb Named Exclusive Global Distributor of Alfa Instruments s.r.l. Intraocular Dyes

PR Newswire September 1, 2022

Bausch + Lomb Announces Participation at Upcoming Investor Conferences

PR Newswire August 29, 2022

Bausch + Lomb Announces Second-Quarter 2022 Results

PR Newswire August 4, 2022

Bausch + Lomb Launches the #LUMIFYEyeDance Challenge on TikTok

PR Newswire July 28, 2022